Plante Moran Financial Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Plante Moran Financial Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5	Closed	–	–	882
2019 Q4	$0	Buy	+5	New	+$65	﹤0.01%	938
2016 Q3	–	Sell	-106	Closed	-$8K	–	1010
2016 Q2	$8K	Buy	+106	New	+$20.2K	0.01%	565

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return